HS

HighVista Strategies Portfolio holdings

AUM $272M
This Quarter Return
-1.91%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$151M
AUM Growth
+$151M
Cap. Flow
+$11.5M
Cap. Flow %
7.61%
Top 10 Hldgs %
48.77%
Holding
155
New
39
Increased
47
Reduced
18
Closed
28

Top Buys

1
CPNG icon
Coupang
CPNG
$7.14M
2
PPD
PPD, Inc. Common Stock
PPD
$3.51M
3
KSU
Kansas City Southern
KSU
$3.49M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
$3.39M
5
FIVN icon
FIVE9
FIVN
$2.78M

Top Sells

1
WTW icon
Willis Towers Watson
WTW
$9.44M
2
MXIM
Maxim Integrated Products
MXIM
$4.49M
3
ALXN
Alexion Pharmaceuticals Inc
ALXN
$3.96M
4
WORK
Slack Technologies, Inc.
WORK
$3.57M
5
SOGO
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$3.07M

Sector Composition

1 Healthcare 44.08%
2 Technology 31.3%
3 Consumer Discretionary 7.05%
4 Communication Services 3.66%
5 Industrials 2.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FATE icon
51
Fate Therapeutics
FATE
$115M
$1.02M 0.67%
17,134
+6,006
+54% +$356K
IGMS
52
DELISTED
IGM Biosciences
IGMS
$1.02M 0.67%
15,446
+4,965
+47% +$327K
BEAM icon
53
Beam Therapeutics
BEAM
$1.9B
$998K 0.66%
+11,474
New +$998K
LENZ
54
LENZ Therapeutics
LENZ
$1.12B
$998K 0.66%
+60,905
New +$998K
SWTX
55
DELISTED
SpringWorks Therapeutics
SWTX
$989K 0.65%
15,594
+4,963
+47% +$315K
RPTX icon
56
Repare Therapeutics
RPTX
$73.9M
$947K 0.63%
+36,104
New +$947K
VERV
57
DELISTED
Verve Therapeutics
VERV
$883K 0.58%
+18,782
New +$883K
SNDX icon
58
Syndax Pharmaceuticals
SNDX
$1.39B
$872K 0.58%
45,584
-2,230
-5% -$42.7K
DBC icon
59
Invesco DB Commodity Index Tracking Fund
DBC
$1.28B
$856K 0.57%
42,396
– –
ATHM icon
60
Autohome
ATHM
$3.44B
$728K 0.48%
15,521
-15,433
-50% -$724K
AVIR icon
61
Atea Pharmaceuticals
AVIR
$275M
$724K 0.48%
20,659
-16,636
-45% -$583K
OCUL icon
62
Ocular Therapeutix
OCUL
$2.25B
$691K 0.46%
69,062
+7,423
+12% +$74.3K
YUMC icon
63
Yum China
YUMC
$16.3B
$684K 0.45%
11,771
+2,893
+33% +$168K
APLS icon
64
Apellis Pharmaceuticals
APLS
$3.51B
$651K 0.43%
+19,763
New +$651K
RVMD icon
65
Revolution Medicines
RVMD
$7.43B
$650K 0.43%
23,637
-1,401
-6% -$38.5K
EWTX icon
66
Edgewise Therapeutics
EWTX
$1.54B
$650K 0.43%
39,133
+11,666
+42% +$194K
BIDU icon
67
Baidu
BIDU
$33.1B
$622K 0.41%
4,043
-164
-4% -$25.2K
FMTX
68
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$619K 0.41%
26,711
-1,974
-7% -$45.7K
OLMA icon
69
Olema Pharmaceuticals
OLMA
$432M
$579K 0.38%
20,999
-8,123
-28% -$224K
NRIX icon
70
Nurix Therapeutics
NRIX
$723M
$563K 0.37%
18,796
-10,584
-36% -$317K
PTGX icon
71
Protagonist Therapeutics
PTGX
$3.62B
$501K 0.33%
28,311
+2,458
+10% +$43.5K
SPRY icon
72
ARS Pharmaceuticals
SPRY
$1.08B
$224K 0.15%
22,434
-3,472
-13% -$34.7K
SPOK icon
73
Spok Holdings
SPOK
$371M
$160K 0.11%
15,666
+3,374
+27% +$34.5K
GRTS
74
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$156K 0.1%
+14,453
New +$156K
ALPN
75
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$152K 0.1%
+14,268
New +$152K
1 2
3
4 5